Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment

doi:10.4331/wjbc.v5.i3.377

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6304)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series.

Item

Count

PDF

312

WORD

293

HTML

3619

Figures (1-9)

200

Sum=4424

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

976

Download

904

Sum=1880

Aug 26, 2014 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Biol Chem. Aug 26, 2014; 5(3): 377-386
Published online Aug 26, 2014. doi: 10.4331/wjbc.v5.i3.377

Full Size Figure Download Figure

Figure 2 Protein content of Sirt1 and Sirt3. Doxorubicin (Dox) did not affect the expression of Sirt1 or Sirt 3 in liver of treated animals. Representative Western blot shows 120 kDa Sirt1. A 45 kDa species detected by the Sirt1 antibody is also shown. Sirt: Sirtuin.

Citation: Dirks-Naylor AJ, Kouzi SA, Bero JD, Tran NT, Yang S, Mabolo R. Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment. World J Biol Chem 2014; 5(3): 377-386
URL: https://www.wjgnet.com/1949-8454/full/v5/i3/377.htm
DOI: https://dx.doi.org/10.4331/wjbc.v5.i3.377